The DOI matches its Crossref record; 77 of the 78 references it cites were found in a registry or an index.
Insulin–PI3K signalling: an evolutionarily insulated metabolic driver of cancer
Open accessAbstract
Cancer is driven by incremental changes that accumulate, eventually leading to oncogenic transformation. Although genetic alterations dominate the way cancer biologists think about oncogenesis, growing evidence suggests that systemic factors (for example, insulin, oestrogen and inflammatory cytokines) and their intracellular pathways activate oncogenic signals and contribute to targetable phenotypes. Systemic factors can have a critical role in both tumour initiation and therapeutic responses as increasingly targeted and personalized therapeutic regimens are used to treat patients with cancer. The endocrine system controls cell growth and metabolism by providing extracellular cues that integrate systemic nutrient status with cellular activities such as proliferation and survival via the production of metabolites and hormones such as insulin. When insulin binds to its receptor, it initiates a sequence of phosphorylation events that lead to activation of the catalytic activity of phosphoinositide 3-kinase (PI3K), a lipid kinase that coordinates the intake and utilization of glucose, and mTOR, a kinase downstream of PI3K that stimulates transcription and translation. When chronically activated, the PI3K pathway can drive malignant transformation. Here, we discuss the insulin-PI3K signalling cascade and emphasize its roles in normal cells (including coordinating cell metabolism and growth), highlighting the features of this network that make it ideal for co-option by cancer cells. Furthermore, we discuss how this signalling network can affect therapeutic responses and how novel metabolic-based strategies might enhance treatment efficacy for cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although not covered in this review, the importance of aberrant functions of different PLCs and PI3Ks in disease development is well established and continues to expand [11,62,67,72,134–138].”
From Phosphatidylinositol(4,5)bisphosphate: diverse functions at the plasma membrane (2020) · cites this paper as [67]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“p110α heterodimers play a key role in glucose homeostasis and in insulin and growth factor signalling [65–67].”
From Phosphatidylinositol(4,5)bisphosphate: diverse functions at the plasma membrane (2020) · cites this paper as [67]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0095 · Cited by 17,455
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Self-citationIntegrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Gao, J., Aksoy, B. A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S. O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004088 · Cited by 15,160
On Respiratory Impairment in Cancer Cells
Warburg, O. H. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,472
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Engelman, J. A., Luo, J., & Cantley, L. C. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1879 · Cited by 3,330
Self-citationThe PI3K Pathway in Human Disease
Fruman, D. A., Chiu, H., Hopkins, B. D., Bagrodia, S., Cantley, L. C., & Abraham, R. T. (2017) · Cell · doi:10.1016/j.cell.2017.07.029 · Cited by 2,749
Self-citationAlpelisib for PIK3CA -Mutated, Hormone Receptor–Positive Advanced Breast Cancer
André, F., Ciruelos, E., Rubovszky, G., Campone, M., Loibl, S., Rugo, H. S., Iwata, H., Conte, P., Mayer, I. A., Kaufman, B., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1813904 · Cited by 2,622
Cancer cell metabolism: warburg and beyond
Hsu, P. P., & Sabatini, D. M. (2008) · Cell · doi:10.1016/j.cell.2008.08.021 · Cited by 2,452
Insulin and insulin-like growth factor signalling in neoplasia
Pollak, M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2536 · Cited by 2,059
Cited by
Sorted by citations
Items 201–288 of 288
Kotova, P. D., Dymova, E. A., Lyamin, O. O., Rogachevskaja, O. A., & Kolesnikov, S. S. (2024) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2024.130649 · Cited by 2
Synergistic Modulation of ER Stress and Insulin Potentiation Therapy for Enhanced Cancer Treatment
Al-Damook, N., Sakkal, M., Kremesh, S., Mousa, W. K., Khair, M., Khoder, G., & Ghemrawi, R. (2025) · Cell Therapy & Engineering Connect · doi:10.69709/cellengc.2025.115467 · Cited by 2
Bouali, W., Bouali, M., Genç, A. A., & Erk, N. (2025) · Ankara Universitesi Eczacilik Fakultesi Dergisi · doi:10.33483/jfpau.1579369 · Cited by 2
Mutations in tumor signaling, metastases, and synthetic lethality establish distinct patterns
Yavuz, B. R., Sahin, U., Jang, H., Nussinov, R., & Tunçbağ, N. (2025) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1013351 · Cited by 3
Circling back to PTEN: Fumarate inhibits canonical tumor suppressor
Claridge, S. E., & Hopkins, B. D. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.03.013 · Cited by 2
Self-citationSHEHABELDIN, M. S. N. M. H. N., & MOHAMED, M. D. M. A. A. Z. H. K. (2022) · The Medical Journal of Cairo University/The Medical Journal of Cairo University · doi:10.21608/mjcu.2022.264607 · Cited by 2
Agu, I., José, I. R., & Díaz‐Muñoz, S. L. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.04.602134 · Cited by 2
Krentz, A. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91707-0.00001-2 · Cited by 1
Song, R., Stopsack, K. H., Ren, J., Mucci, L. A., Clinton, S. K., Loda, M. F., Wang, M., Giovannucci, E. L., Wilson, K. M., & Smith‐Warner, S. A. (2024) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2024.07.001 · Cited by 2
Yang, Y., Chen, Y., Liu, C., Wang, S., Zhao, Y., Cao, W., & Wang, K. (2025) · Journal of Diabetes Research · doi:10.1155/jdr/6251747 · Cited by 1
Improved ASCVD Screening in Diabetes: a Focus on Scoring Models and Detection Techniques
Zanfirescu, R.-L., Anghel, L., Tudurachi, B.-S., Clement, A.-M., Zăvoi, A., Benchea, L.-C., Ciocoiu, M., Sascău, R. A., Stătescu, C., & Radu, R. (2025) · Romanian Journal of Internal Medicine · doi:10.2478/rjim-2025-0009 · Cited by 1
Huang, J., & Zhu, X. M. (2025) · Next research. · doi:10.1016/j.nexres.2025.100490 · Cited by 1
Leps, C., Bischoff, C., Gockel, I., Tegtbur, U., Kwast, S., Pökel, C., Voß, J., Rinser, H.-J., Falz, R., & Busse, M. W. (2025) · BMC Sports Science Medicine and Rehabilitation · doi:10.1186/s13102-025-01275-3 · Cited by 2
Li, S., Li, S., Kong, D., Yao, Q., & Fu, W. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152560 · Cited by 1
Wang, Z., Ma, R.-F., Gu, L.-C., Wang, L.-Z., Chen, T., Yang, P., Zou, J.-N., Zhu, J., Wu, Z.-W., Zhou, Y., et al. (2025) · The EMBO Journal · doi:10.1038/s44318-025-00636-5 · Cited by 1
Agu, I., José, I. R., Ram, A. R., Oberbauer, D., Albeck, J. G., & Díaz‐Muñoz, S. L. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02598-x · Cited by 1
Liu, X. W., Chen, Y., Li, G., Chen, A., Zhou, Q. R., & Wang, M. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.07.003 · Cited by 2
Omer, A. B., Afzal, M., Saleem, S., Khan, M. M. U., Rekha, A., & Sharma, R. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12403-8 · Cited by 1
Gordon, S. R., Reaume, D. R., & Perkins, T. R. (2020) · Growth Factors · doi:10.1080/08977194.2021.1963721 · Cited by 1
Ketogenic Diet as Adjunctive Therapy for Malignant Brain Cancer
Scheck, A. C., & Syed, N. (2022) · Oxford University Press eBooks · doi:10.1093/med/9780197501207.003.0015 · Cited by 1
Schimpf, A. R. A., Formichela, M. M., Mascheroni, M. B., Rivero, D., Chamorro, M. L., Portillo, V., Zapata, P. D., & Ferri, C. A. (2022) · Revista de Ciencia y Tecnología · doi:10.36995/j.recyt.2022.37.009 · Cited by 1
Ding, Z., Cao, L., Jin, R., & Li, R. (2023) · Clinical and Experimental Obstetrics & Gynecology · doi:10.31083/j.ceog5004073 · Cited by 1
Liu, R., Liu, H., Li, R., Li, C., Xiao, H., & Chen, S. (2025) · Tropical Animal Health and Production · doi:10.1007/s11250-025-04357-z · Cited by 1
Extensive genotype-phenotype heterogeneity in renal cell carcinoma - a proof-of-concept study
Wieke, J., Jurcic, C., Kaczorowski, A., Böning, S. H., Kirchner, M., Schwab, C., Schütz, V., Hohenfellner, M., Duensing, A. U., Stenzinger, A., et al. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1551077 · Cited by 1
Yuan, X., Zhang, K., Wang, D., Li, J., Lyu, P., Zhao, X., Zhang, K., Li, H., Liu, B., & Ma, L. (2025) · Liver International · doi:10.1111/liv.70302 · Cited by 2
The Role of C-reactive Protein in Aging associated NAFLDPreprint
Ding, Z., Wei, Y., Peng, J., Wang, S., Chen, G., & Sun, J. (2023) · Preprints.org · doi:10.20944/preprints202307.1406.v1
A JAK/STAT-Pdk1-S6K axis bypasses systemic growth restrictions to promote regenerationPreprint
Maya, A. V., Neuhaus, L., Nogay, L., Singh, A., Heckmann, L., Grass, I., Buescher, J. M., Kierdorf, K., & Classen, A.-K. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.05.606658 · Cited by 1
Beyond Base Camp: Promise and Pitfalls of PI3K/mTOR Inhibition in Pediatric High- Grade GliomasPreprint
Duchatel, R. J., Savary, C., Germon, Z. P., Riley, M., Ziegler, D. S., Mueller, S., Jackson, E. R., & Dun, M. D. (2025) · Research Square · doi:10.21203/rs.3.rs-6508597/v1 · Cited by 1
Yavuz, B. R., Sahin, U., Jang, H., Nussinov, R., & Tunçbağ, N. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.01.592039 · Cited by 1
de Souza, K. S. S., de Almeida, A. C., de Oliveira, S. P., Brandi, I., Santos, S. S., da Fonseca, F. S. A., Santos, E. M. S., Oliveira, J. R., de Freitas, D. F., Lelis, D. D. F., et al. (2021) · Research Society and Development · doi:10.33448/rsd-v10i4.13826
Epinephrine inhibits PI3K alpha via the Hippo kinasesPreprint
Lin, T.-Y., Ramsamooj, S., Liberatore, K. M., Lantier, L., Vasan, N., Karukurichi, K. R., Hwang, S., Kesicki, E. A., Kastenhuber, E. R., Wiederhold, T., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.19.500601
Self-citationObesity promotes breast epithelium DNA damage in BRCA mutation carriersPreprint
Bhardwaj, P., Iyengar, N. M., Zahid, H., Carter, K. M., Byun, D. J., Choi, M. H., Sun, Q., Savenkov, O., Louka, C., Liu, C., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.29.502090
Self-citationNorouzi, M., Saghi, H., Mohebbati, R., Mirzavi, F., Afshari, A. R., & Soukhtanloo, M. (2022) · PubMed Central · doi:10.22038/ajp.2022.19982
Emergent impact of lifestyle on tumor progression and response to therapy
Buqué, A., Montrose, D. C., & Galluzzi, L. (2022) · International review of cytology · doi:10.1016/s1937-6448(22)00132-0
Monitoring Agonist-Induced Activity of PI3-Kinase in HEK-293 with a Genetically Encoded Sensor
Kotova, P. D., Rogachevskaja, O. A., Kabanova, N. V., & Kolesnikov, S. S. (2022) · Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology · doi:10.1134/s1990747822050099
Katsagoni, C. N., Kokkinos, P. F., & Sidossis, L. S. (2023) · Wiley eBooks · doi:10.1002/9781119833475.ch21
范, 志. (2023) · Hans Journal of Medicinal Chemistry · doi:10.12677/hjmce.2023.112011
Taheri, Z., Noroozi, N., & Amoli, M. M. (2023) · Advances in Surgical Sciences · doi:10.11648/j.ass.20231101.12
Glucose metabolism disorders in cancer patients
Różycka, K., & Kapała, A. (2023) · Nowotwory Journal of Oncology · doi:10.5603/njo.a2023.0034
Lin, Q., Liu, J., Chen, H., Hu, W., Lei, W., Wang, M., Lin, X., Zhang, Y., Ai, H., Chen, S., et al. (2023) · Current Protein and Peptide Science · doi:10.2174/0113892037249620231010063637
Glycemic Traits and Oesophageal Cancer a Two-Sample and Multivariable Mendelian Randomization StudyPreprint
Chen, Y., Zeng, Q., Li, M., Chen, K., & Zhao, J. (2023) · Research Square · doi:10.21203/rs.3.rs-3490256/v1
Chen, Y., Zeng, Q., Li, M., Chen, K., & Zhao, J. (2023) · Research Square · doi:10.21203/rs.3.rs-3717733/v1
Khodashahi, R., Beiraghdar, F., Ferns, G. A., Ashrafzadeh, K., Aliakbarian, M., & Arjmand, M. (2024) · Current Cancer Drug Targets · doi:10.2174/0115680096281059240103154836
PI3 kinase-unrelated effects of LY294002 and LY303511 on serotonin-induced Ca 2+ and cAMP signalingPreprint
Kotova, P. D., Dymova, E. A., Rogachevskaja, O. A., & Kolesnikov, S. S. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.05.592569
Mancini, C., Mazzilli, R., & Faggiano, A. (2024) · L Endocrinologo · doi:10.1007/s40619-024-01476-x
Alvandi, S. J., Ghoraeian, P., Alizadeh, A., Aghajanpour, S., Emami, N., Moini, A., Shahhoseini, M., Schmutzler, A. G., & Hafezi, M. (2024) · Research Square · doi:10.21203/rs.3.rs-4670310/v1
Ablation of PI3Kγ in neurons protects mice from diet-induced obesity MASLD and insulin resistance
Molinaro, A., Mazzoli, A., Gaudi, A. U., Gupta, A. C., Silva, V. R. R., Ramel, D., Laffargue, M., Ruud, J., Becattini, B., & Solinas, G. (2024) · iScience · doi:10.1016/j.isci.2024.111562
A Prognostic Survival Model Based on Endocrine-Related Gene Expression in Acute Myelogenous Leukemia
Lv, W., Wang, Y., Hu, F., Huang, H.-Y., Cui, Y., Song, Y., Chen, L., Wu, B., & Liang, Y. (2025) · Acta Haematologica · doi:10.1159/000543272
Biological Applications of Acacia Gums (AGs) SME on Breast Cancer Cell Lines
Elnour, A. A. M., Nour, A. H., Mokaizh, A. A. B., & Mirghani, M. E. S. (2025) · Springer eBooks · doi:10.1007/978-981-97-8518-6_8
Zhang, J., Chen, X., & Wang, Y. (2025) · Frontiers in Cancer Control and Society · doi:10.3389/fcacs.2025.1579705
Pleiotropic Effects of Metformin on the Chemotherapy Response of HPV‐Positive Cancer Cells
Avenhaus, A., Kuhn, B. J., Velimirović, M., Strobel, T. D., Bulkescher, J., Lohrey, C., Krijgsveld, J., Hoppe‐Seyler, F., & Hoppe‐Seyler, K. (2025) · Journal of Medical Virology · doi:10.1002/jmv.70434
Identification of A Novel Mutation of SHORT Syndrome: A Case Report
Huynh, Q. T. V., Luong, T. T., Ban, H. T., & Tran, V. (2025) · Clinical Case Reports · doi:10.1002/ccr3.70820
Serum ATIC Expression as a Novel Diagnostic and Prognostic Biomarker in Multiple Myeloma Patients
Gu, M., Zheng, Y., Wang, Y., Wang, Q., Wu, J., Xiong, Z., Nong, Y., Huang, C., Li, Z., Luo, J., et al. (2025) · Blood and Lymphatic Cancer Targets and Therapy · doi:10.2147/blctt.s537524
Li, M., Zhang, R., Sheikho, A., Tang, J.-J., Gao, Y., Huang, W.-W., & Gao, J. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.147547
RetractedSerotonin 5-HT 2C receptor as a cellular target of PI3K inhibitor LY294002 and its analog LY303511Preprint
Kotova, P. D., Dymova, E. A., Lyamin, O. O., Rogachevskaja, O. A., Voronova, E. A., & Kolesnikov, S. S. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.06.687025
Dietary Fat Content Influences PanIN Progression and Pancreatic Cancer Development in Mice
Sardarni, U. K., Faraoni, E. Y., Waller, A., Strickland, L. N., O’Brien, B. J., Klute, K. A., Cox, J. L., McAllister, F. M., & Bailey, J. M. (2026) · Cancer Research Communications · doi:10.1158/2767-9764.crc-25-0777
Li, Y., Zhao, T., Gao, W., Miao, B., Fu, Z., Zhang, Z., Li, Q., & Sun, D. (2024) · Figshare · doi:10.6084/m9.figshare.25530339
Li, Y., Zhao, T., Gao, W., Miao, B., Fu, Z., Zhang, Z., Li, Q., & Sun, D. (2024) · Figshare · doi:10.6084/m9.figshare.25530412
Wang, L., Lin, Y., Liao, Y., & Shen, J. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1569824
Kim, S.-H., Kim, J. S., Yoo, J., Jeong, K., Kim, J., Cho, Y.-S., Park, J. B., Koh, J., Kong, S., Park, D. J., et al. (2025) · Obesity Surgery · doi:10.1007/s11695-025-08389-0
Zheng, B., Wang, H., Xiao, Y., Wu, F., Yang, C., Sheng, R., & Zeng, M. (2026) · Insights into Imaging · doi:10.1186/s13244-025-02183-3
Diabetes and cancer: therapeutic implications
Fay, S., Bayshtok, G., HAMO, C. E., Butler, J., & Bloom, M. W. (2026) · Cardio-Oncology · doi:10.1186/s40959-025-00412-8
Jan, I., Ali, T., Bashir, R., Khaki, P. S. S., Andrabi, K. I., & Bader, G. N. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-23908-3.00018-6
Chen, Y., Ullah, M. M., Al-Khalaifah, H. S., & Hassan, F. (2026) · Poultry Science · doi:10.1016/j.psj.2026.106667
Wang, Y., Zhao, R., Yuan, Z., Zhai, L., Ning, X., Lv, M., Jin, Z., Iqbal, H., Ur-Rehman, U., Yi, Z., et al. (2026) · iScience · doi:10.1016/j.isci.2026.115389 · Cited by 2
Abedi, A., Moghaddam, M. M., Kachuei, R., & Fooladi, A. A. I. (2026) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-026-01171-5
Roisné-Hamelin, G. (2024) · theses.fr (ABES) · doi:10.70675/006069a1zb2b5z45e8zbe4fz5af5e3b6e229
Komatsu, T., & Inagaki, T. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.14.718598
Diabetes and cancer: clinical implications for integrated metabolic–oncologic care
Fuchs-Tarlovsky, V. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1824109
Schmitz, S. M., Grünwald, B., Tasdogan, A., Heise, D., Bednarsch, J., Heij, L. R., Reschke, M. A., Ulmer, T. F., Neumann, U. P., & Lang, S. A. (2026) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2026.102853
Al‐Sayegh, M., Khalili, M., Alzaabi, M., Sultana, M., Ali, L., Ali, M. O. I., & El-Hadidi, M. (2026) · Adipocyte · doi:10.1080/21623945.2026.2680625
Wakens, A., Joseph, D. E., & Rambharose, S. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113354
Li, Y., HOU, Y., Han, Y., Feng, W., Zong, W., Wang, X., Chen, G., Tan, X., Zhang, B., Ju, L., et al. (2026) · Cellular Signalling · doi:10.1016/j.cellsig.2026.112675
Kim, J. H., Ahn, E.-K., Chang, H. K., Kim, S.-J., Kim, J., Park, S. J., & Heo, J. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27136023
Metabolism in PTEN hamartoma tumour syndrome
Ambery, P., Bågenholm, R., Pepper, T., Barton, C. M., Whitehead, M. A., Rodriguez, L. H., & Greasley, P. J. (2026) · Metabologia · doi:10.1007/s44357-026-00008-4
The circadian architecture of tumor immunity: mechanistic insights and treatment strategies
Wang, H. Y., Guo, B., Li, D., Liu, Y., Cheng, K., Zhang, W., & Liang, H. (2026) · Biomarker Research · doi:10.1186/s40364-026-00972-6
Homeostasis and Regulation of Metabolism in Human Health
Minden, A. (2026) · Springer eBooks · doi:10.1007/978-3-032-20529-2_12
Cingoz, H., Asif, H., & Kim, J. J. (2026) · Epigenetics Insights · doi:10.48130/epi-0026-0007
Modulation of Noradrenaline-Induced cAMP Production in HEK-293 Cells by Insulin
Dymova, E. A., Rogachevskaja, O. A., Котова, П. Д., Коваленко, Н. П., & Kolesnikov, S. S. (2026) · Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology · doi:10.1134/s1990747826700170
Borbei, R., Brata, V. D., Dobrotă, I. R., Ceteraș, L.-M., Clim, M., Alexescu, T., Milaciu, M. V., Perné, M.-G., Gerdanovics, C.-A., Procopciuc, L. M., et al. (2026) · Diagnostics · doi:10.3390/diagnostics16162616
Agu, I., Gomez, S. Y., José, I. R., & Díaz‐Muñoz, S. L. (2026) · Applied and Environmental Microbiology · doi:10.1128/aem.01232-26
Chen, C., Holmes, R., Carter, J., Maity, S., Pawley, S. B., Stahl, N., Crossan, A., Rager, J. D., Juvekar, A., Wang, M., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c00269
Asiri, A., Otaibi, A. A., Tasleem, M., Mubarak, S. A. S., Said, M. A., Mihmadi, Y. A. A., Subei, B. A., Asiri, A., Qarni, A. A., & Bakillah, A. (2026) · Biomedicines · doi:10.3390/biomedicines14092133
Cooper, I. D., Petagine, L., Cooper, N., Soto-Mota, A., Edwards, K., Kraev, I., Lange, S., & Kyriakidou, Y. (2026) · Clinical bioenergetics · doi:10.3390/clinbioenerg2040016
BindingDB (2024) · UC San Diego · doi:10.7270/q2rf60hx
Metadata
- Authors
- Hopkins, B. D., Goncalves, M. D., & Cantley, L. C.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- Weill Cornell Medicine (US)
- Corresponding author
- Hopkins, Benjamin D.
- Venue
- Nature Reviews Endocrinology
- Published
- 2020-03-03
- Volume
- 16
- Issue
- 5
- Pages
- 276-283
- ISSN
- 1759-5029 (ISSN-L)
- 1759-5037
- PMC
- PMC7286536
- OpenAlex
- W3009258273
- Cited by
- 288
- References
- 78
- Citations by year
- 2026: 34 · 2025: 50 · 2024: 46 · 2023: 52 · 2022: 45 · 2021: 41 · 2020: 20
- FWCI
- 3.81
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature Reviews Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (K08CA230318, R00CA230384, R35CA197588)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- insulin signaling, PI3K signaling, mTOR, oncogenic transformation, cancer metabolism, insulin resistance, insulin receptor, cancer therapy resistance, metabolic targeting, tumor initiation
- MeSH terms
- Animals, Endocrine System, Biological Evolution, Humans, Insulin, Neoplasms, Signal Transduction, Phosphatidylinositol 3-Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review